Related Experiment Video
Updated: Aug 12, 2026

Rapid Point-of-Care Assay of Enoxaparin Anticoagulant Efficacy in Whole Blood
Published on: October 12, 2012
[Enoxaparin (clexane) in the prevention of thromboembolism after total hip replacement]
I Babiak1, T Jabłoński, J Serafin
1Kliniki Ortopedycznej AM w Warszawie.
The efficiency and safety of use of enoxaparin (clexane Rhone-Poulenc Rorer) in antithrombotic prophylaxis after total hip replacement is presented. The subcutaneous dose of 40 mg daily proved to be highly efficient and of minor side-effects.
The efficiency and safety of use of enoxaparin (clexane Rhone-Poulenc Rorer) in antithrombotic prophylaxis after total hip replacement is presented. The subcutaneous dose of 40 mg daily proved to be highly efficient and of minor side-effects.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Peripheral Artery Disease V: Postoperative Nursing Management
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis IV: Nursing Management
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

